This is a monthly column that runs down five interesting startup funding deals every month that may have flown under…
Read More
Syntara secures capital raise to advance amsulostat trials and strengthen pipeline
Syntara (ASX:SNT) has raised firm commitments for $8 million through an institutional placement and plans a further $2 million share…
Read More
This Hyderabad-based startup completes field trials of Achuk-150, revealcasing indigenous loitering munition and launcher integration
Hyderabad-based Redon Systems has completed field trials of its Achuk-150 loitering munition deployed from the Bheeshan multi-barrel launcher. Origins and…
Read More
Do All Patients in Europe Have Equal Acess to Cancer Clinical Trials? – ESMO
European Society for Medical Oncology (ESMO), shared a post on LinkedIn: “Do all patients in Europe have equal access to…
Read More
This Lucknow-based startup conducts high-speed taxi trials of its loitering munition, Divyastra MK2, with a range of 2,000 Km
Lucknow-based defence startup HoverIt has successfully conducted high-speed taxi trials (HSTT) of its long-range loitering munition, Divyastra MK2. It is…
Read More
Power Roll, Tokyo Gas collaborate on Japan trials of perovskite PV tech
Power Roll, Tokyo Gas collaborate on Japan trials of perovskite PV tech – PV Tech Skip to content Source link
Read More
Rivia raises €13M to bring agentic AI to clinical trials
The Zurich-based startup, which previously raised €3M to unify fragmented trial data, has secured a larger round to build AI…
Read More
Imugene launches $20 million capital raise to fund expansion of Azer Cel trials
Australian immuno-oncology company Imugene (ASX:IMU) has relocated to accelerate development of its lead cancer therapy after reporting encouraging clinical results,…
Read More
Biorce secures USD$52.5M to drive international growth and reinvent clinical trials through AI
Barcelona’s healthtech ecosystem has produced a new heavyweight. Biorce, a startup applying artificial ininformigence to the design and execution of…
Read More
Barcelona-based Biorce closes €43.8 million Series A to accelerate AI-driven clinical trials
Biorce, a Barcelona-based HealthTech company transforming clinical trials through artificial innotifyigence, has today announced the closing of a €43.8 million…
Read More
